JP2017513866A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513866A5 JP2017513866A5 JP2016563193A JP2016563193A JP2017513866A5 JP 2017513866 A5 JP2017513866 A5 JP 2017513866A5 JP 2016563193 A JP2016563193 A JP 2016563193A JP 2016563193 A JP2016563193 A JP 2016563193A JP 2017513866 A5 JP2017513866 A5 JP 2017513866A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- pharmaceutical composition
- composition
- administration
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 20
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims 6
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims 6
- 229960004502 levodopa Drugs 0.000 claims 6
- 230000002685 pulmonary effect Effects 0.000 claims 6
- 208000018737 Parkinson disease Diseases 0.000 claims 5
- 208000012661 Dyskinesia Diseases 0.000 claims 4
- 229940112141 dry powder inhaler Drugs 0.000 claims 4
- 229940071648 metered dose inhaler Drugs 0.000 claims 4
- 239000010419 fine particle Substances 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 229940068196 placebo Drugs 0.000 claims 2
- 239000000902 placebo Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2014/034778 WO2015163840A1 (en) | 2014-04-21 | 2014-04-21 | Rapid relief of motor fluctuations in parkinson's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019039444A Division JP2019108379A (ja) | 2019-03-05 | 2019-03-05 | パーキンソン病の運動症状変動の迅速な緩和 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017513866A JP2017513866A (ja) | 2017-06-01 |
| JP2017513866A5 true JP2017513866A5 (enExample) | 2019-04-25 |
Family
ID=54332876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016563193A Pending JP2017513866A (ja) | 2014-04-21 | 2014-04-21 | パーキンソン病の運動症状変動の迅速な緩和 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20170296498A1 (enExample) |
| EP (2) | EP3831375A1 (enExample) |
| JP (1) | JP2017513866A (enExample) |
| KR (2) | KR20170008754A (enExample) |
| CN (2) | CN106659685B (enExample) |
| AU (2) | AU2014391721B2 (enExample) |
| BR (1) | BR112016024502A8 (enExample) |
| CA (1) | CA2946165C (enExample) |
| IL (2) | IL309959A (enExample) |
| MX (1) | MX2016013741A (enExample) |
| RU (1) | RU2698330C2 (enExample) |
| SG (1) | SG11201608608PA (enExample) |
| WO (1) | WO2015163840A1 (enExample) |
| ZA (1) | ZA201607833B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015010601B1 (pt) | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | Composição farmacêutica e uso da composição |
| EP3735298A4 (en) * | 2018-01-05 | 2021-10-06 | Impel Neuropharma Inc. | INTRANASAL ADMINISTRATION OF LEVODOPA POWDER BY N BY AN OLFACTORIC PRECISION DEVICE |
| JP2021532098A (ja) | 2018-07-19 | 2021-11-25 | インペル ニューロファーマ インコーポレイテッド | パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| SI2630954T1 (sl) * | 2002-03-20 | 2017-02-28 | Civitas Therapeutics, Inc. | Pulmonalno dovajanje za levodopo |
| AR044007A1 (es) * | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | Metodos para el tratamiento de la enfermedad de parkinson |
| US8496002B2 (en) | 2007-06-12 | 2013-07-30 | Civitas Therapeutics, Inc. | Powder inhaler devices |
| GB2454480A (en) * | 2007-11-07 | 2009-05-13 | Vectura Group Plc | Pulmonary inhalation of levodopa containing compositions in the treatment of Parkinsons disease and other central nervous system disorders |
| WO2010000763A2 (en) * | 2008-06-30 | 2010-01-07 | Novartis Ag | Combination products |
| US8399513B2 (en) * | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
| TW201304822A (zh) * | 2010-11-15 | 2013-02-01 | Vectura Ltd | 組成物及用途 |
| RU2685718C2 (ru) * | 2012-10-22 | 2019-04-23 | Сивитас Терапьютикс, Инк. | Лекарственные формы леводопы для быстрого купирования болезни паркинсона |
| US8545878B1 (en) * | 2012-11-09 | 2013-10-01 | Civitas Therapeutics, Inc. | Capsules containing high doses of levodopa for pulmonary use |
-
2014
- 2014-04-21 CN CN201480079968.6A patent/CN106659685B/zh active Active
- 2014-04-21 IL IL309959A patent/IL309959A/en unknown
- 2014-04-21 EP EP21150770.2A patent/EP3831375A1/en not_active Ceased
- 2014-04-21 MX MX2016013741A patent/MX2016013741A/es unknown
- 2014-04-21 AU AU2014391721A patent/AU2014391721B2/en active Active
- 2014-04-21 JP JP2016563193A patent/JP2017513866A/ja active Pending
- 2014-04-21 WO PCT/US2014/034778 patent/WO2015163840A1/en not_active Ceased
- 2014-04-21 US US15/500,608 patent/US20170296498A1/en not_active Abandoned
- 2014-04-21 SG SG11201608608PA patent/SG11201608608PA/en unknown
- 2014-04-21 CN CN202110185196.6A patent/CN113209055A/zh active Pending
- 2014-04-21 KR KR1020167032453A patent/KR20170008754A/ko not_active Ceased
- 2014-04-21 BR BR112016024502A patent/BR112016024502A8/pt not_active Application Discontinuation
- 2014-04-21 KR KR1020217038097A patent/KR20210144946A/ko not_active Ceased
- 2014-04-21 EP EP14889874.5A patent/EP3134077A4/en not_active Ceased
- 2014-04-21 CA CA2946165A patent/CA2946165C/en active Active
- 2014-04-21 RU RU2016144340A patent/RU2698330C2/ru active
-
2016
- 2016-10-20 IL IL248445A patent/IL248445A0/en unknown
- 2016-11-14 ZA ZA2016/07833A patent/ZA201607833B/en unknown
-
2020
- 2020-09-24 AU AU2020239754A patent/AU2020239754B2/en active Active
-
2022
- 2022-01-26 US US17/584,663 patent/US20230053976A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2025204271A1 (en) | Microcrystalline diketopiperazine compositions and methods | |
| JP2013224331A5 (enExample) | ||
| JP2011520911A5 (enExample) | ||
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| JP2016534153A5 (enExample) | ||
| HK1203149A1 (en) | Novel dosage form and formulation of abediterol | |
| EA033113B1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
| MX2013015005A (es) | Microparticulas de dicetopiperazina de alta capacidad. | |
| HK1201475A1 (en) | Methods and compositions for treating pain | |
| JP2012193216A5 (enExample) | ||
| JP2014528474A5 (enExample) | ||
| EA201591869A1 (ru) | Композиция, содержащая для повышения стабильности лекарственной формы по меньшей мере два сухих порошка, получаемых распылительной сушкой | |
| JP2015519404A5 (enExample) | ||
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2012502047A5 (enExample) | ||
| RU2019111096A (ru) | Лекарственные формы леводопы для быстрого купирования болезни паркинсона | |
| JP2018527386A5 (enExample) | ||
| JP2017105862A5 (enExample) | ||
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| JP2016512247A5 (enExample) | ||
| JP2015120758A5 (enExample) | ||
| WO2012042197A3 (en) | Low dose pharmaceutical composition comprising zanamivir | |
| JP2016505050A5 (enExample) | ||
| JP2021510682A5 (enExample) | ||
| JP2019507786A5 (enExample) |